Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Psychiatric Illness and Mortality in Hospitalized ESKD Dialysis Patients.

Kimmel PL, Fwu CW, Abbott KC, Moxey-Mims MM, Mendley S, Norton JM, Eggers PW.

Clin J Am Soc Nephrol. 2019 Sep 6;14(9):1363-1371. doi: 10.2215/CJN.14191218. Epub 2019 Aug 22.

PMID:
31439538
2.

Trends in Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia, 2004-2013: The Urologic Diseases in America Project.

Welliver C, Feinstein L, Ward JB, Fwu CW, Kirkali Z, Bavendam T, Matlaga BR, McVary KT; Urologic Diseases in America Project.

J Urol. 2019 Aug 20:101097JU0000000000000499. doi: 10.1097/JU.0000000000000499. [Epub ahead of print]

PMID:
31430232
3.

Epilepsy and antiseizure medications increase all-cause mortality in dialysis patients in the United States.

Waddy SP, Ward JB, Becerra AZ, Powers T, Fwu CW, Williams KL, Eggers PW, Abbott KC, Kimmel PL.

Kidney Int. 2019 May 16. pii: S0085-2538(19)30514-9. doi: 10.1016/j.kint.2019.04.033. [Epub ahead of print]

PMID:
31358345
4.

Opioid Prescription, Morbidity, and Mortality in US Transplant Recipients.

Abbott KC, Fwu CW, Eggers PW, Eggers AW, Kline PP, Kimmel PL.

Transplantation. 2018 Jun;102(6):994-1004. doi: 10.1097/TP.0000000000002057.

5.

Opioid Prescription, Morbidity, and Mortality in United States Dialysis Patients.

Kimmel PL, Fwu CW, Abbott KC, Eggers AW, Kline PP, Eggers PW.

J Am Soc Nephrol. 2017 Dec;28(12):3658-3670. doi: 10.1681/ASN.2017010098. Epub 2017 Sep 21.

6.

Comparison of trends in colorectal cancer screening in the US end-stage renal disease population and the US Medicare population.

Fwu CW, Kimmel PL, Eggers PW, Abbott KC.

Clin Kidney J. 2016 Oct;9(5):722-8. doi: 10.1093/ckj/sfw053. Epub 2016 Jun 20.

7.

Racial Disparities in Poverty Account for Mortality Differences in US Medicare Beneficiaries.

Kimmel PL, Fwu CW, Abbott KC, Ratner J, Eggers PW.

SSM Popul Health. 2016 Dec;2:123-129.

8.

Cross-sectional and longitudinal associations of sexual function with lower urinary tract symptoms in men with benign prostatic hyperplasia.

Fwu CW, Kirkali Z, McVary KT, Burrows PK, Eggers PW, Kusek JW.

J Urol. 2015 Jan;193(1):231-8. doi: 10.1016/j.juro.2014.08.086. Epub 2014 Aug 21.

PMID:
25150638
9.

Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy.

Fwu CW, Eggers PW, Kirkali Z, McVary KT, Burrows PK, Kusek JW.

J Urol. 2014 Jun;191(6):1828-34. doi: 10.1016/j.juro.2013.12.014. Epub 2013 Dec 14.

PMID:
24342143
10.

Long-term effects of doxazosin, finasteride and combination therapy on quality of life in men with benign prostatic hyperplasia.

Fwu CW, Eggers PW, Kaplan SA, Kirkali Z, Lee JY, Kusek JW.

J Urol. 2013 Jul;190(1):187-93. doi: 10.1016/j.juro.2013.01.061. Epub 2013 Jan 25.

PMID:
23357210
11.

Segregation, income disparities, and survival in hemodialysis patients.

Kimmel PL, Fwu CW, Eggers PW.

J Am Soc Nephrol. 2013 Feb;24(2):293-301. doi: 10.1681/ASN.2012070659. Epub 2013 Jan 18.

12.

Emergency department visits, use of imaging, and drugs for urolithiasis have increased in the United States.

Fwu CW, Eggers PW, Kimmel PL, Kusek JW, Kirkali Z.

Kidney Int. 2013 Mar;83(3):479-86. doi: 10.1038/ki.2012.419. Epub 2013 Jan 2.

13.

Preventing renal and cardiovascular risk by renal function assessment: insights from a cross-sectional study in low-income countries and the USA.

Cravedi P, Sharma SK, Bravo RF, Islam N, Tchokhonelidze I, Ghimire M, Pahari B, Thapa S, Basnet A, Tataradze A, Tinatin D, Beglarishvili L, Fwu CW, Kopp JB, Eggers P, Ene-Iordache B, Carminati S, Perna A, Chianca A, Couser WG, Remuzzi G, Perico N.

BMJ Open. 2012 Sep 22;2(5). pii: bmjopen-2012-001357. doi: 10.1136/bmjopen-2012-001357. Print 2012.

14.

Prevalence and trends of urinary incontinence in adults in the United States, 2001 to 2008.

Markland AD, Richter HE, Fwu CW, Eggers P, Kusek JW.

J Urol. 2011 Aug;186(2):589-93. doi: 10.1016/j.juro.2011.03.114.

15.

Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.

Fwu CW, Chien YC, You SL, Nelson KE, Kirk GD, Kuo HS, Feinleib M, Chen CJ.

Hepatology. 2011 Apr;53(4):1217-25. doi: 10.1002/hep.24150.

PMID:
21480326
16.

Mortality after chronic hepatitis B virus infection: a linkage study involving 2 million parous women from Taiwan.

Fwu CW, Chien YC, Nelson KE, Kirk GD, You SL, Kuo HS, Feinleib M, Chen CJ.

J Infect Dis. 2010 Apr 1;201(7):1016-23. doi: 10.1086/651231.

PMID:
20187745
17.

Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.

Fwu CW, Chien YC, Kirk GD, Nelson KE, You SL, Kuo HS, Feinleib M, Chen CJ.

J Natl Cancer Inst. 2009 Jul 15;101(14):1019-27. doi: 10.1093/jnci/djp146. Epub 2009 Jun 17.

PMID:
19535774

Supplemental Content

Support Center